RecruitingPHASE1, PHASE2NCT05272293

Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AML

Studying Inherited acute myeloid leukemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology
Principal Investigator
Olga Aleinikova, MD, Prof, MD
Belarussian Research Center for Pediatric Oncology, Hematology and Immunology
Intervention
NK cell infusions(biological)
Enrollment
15 enrolled
Eligibility
30 years · All sexes
Timeline
2021 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05272293 on ClinicalTrials.gov

Other trials for Inherited acute myeloid leukemia

Additional recruiting or active studies for the same condition.

See all trials for Inherited acute myeloid leukemia →

← Back to all trials